 In addition patients will be considered to have failed treatment if they have a PDAI score improvement of or 2 points at the end of the trial. Patients will be discontinued from the study if they become pregnant or if warranted by treatment-emergent safety concerns or if, in the opinion of the investigator, it is in the patients best interest to discontinue the study. 